Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Rhea-AI Summary

Organogenesis Holdings Inc. (ORGO) to participate in the BTIG Snowbird MedTech Conference without a formal presentation.

CANTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th-14th.

Management will participate in 1x1 meetings on Wednesday, February 14th. There will be no formal presentation.

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com.

FAQ

When will Organogenesis Holdings Inc. participate in the BTIG Snowbird MedTech Conference?

Organogenesis Holdings Inc. will participate in the BTIG Snowbird MedTech Conference from February 13th-14th, with 1x1 meetings scheduled for February 14th.

What is the focus of Organogenesis Holdings Inc.?

Organogenesis Holdings Inc. is a regenerative medicine company specializing in product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

Where will the BTIG Snowbird MedTech Conference take place?

The BTIG Snowbird MedTech Conference will be held at the Cliff Lodge in Snowbird, UT.